Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Acute Myeloid Leukemia Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment Type
6.1 Cytarabine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anthracycline Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alkylating Agents
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Anti-Metabolites
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tyrosine Kinase Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Small Molecule Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biopharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbvie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Celgene
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Roche Holding AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Gilead Sciences Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Acute Myeloid Leukemia Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Treatment Type (in %), 2021
Figure 5: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Route of Administration (in %), 2021
Figure 7: Global: Acute Myeloid Leukemia Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Acute Myeloid Leukemia Therapeutics (Cytarabine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Acute Myeloid Leukemia Therapeutics (Anthracycline Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Acute Myeloid Leukemia Therapeutics (Alkylating Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Acute Myeloid Leukemia Therapeutics (Anti-Metabolites) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Acute Myeloid Leukemia Therapeutics (Tyrosine Kinase Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Acute Myeloid Leukemia Therapeutics (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Acute Myeloid Leukemia Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Acute Myeloid Leukemia Therapeutics (Small Molecule Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Acute Myeloid Leukemia Therapeutics (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Acute Myeloid Leukemia Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Acute Myeloid Leukemia Therapeutics (Injectables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2021
Figure 31: United States: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2021
Figure 38: China: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2021
Figure 55: Germany: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Latin America: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2021
Figure 72: Brazil: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Middle East and Africa: Acute Myeloid Leukemia Therapeutics Market: Breakup by Country (in %), 2021
Figure 81: Global: Acute Myeloid Leukemia Therapeutics Industry: SWOT Analysis
Figure 82: Global: Acute Myeloid Leukemia Therapeutics Industry: Value Chain Analysis
Figure 83: Global: Acute Myeloid Leukemia Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Acute Myeloid Leukemia Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 3: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 5: Global: Acute Myeloid Leukemia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Acute Myeloid Leukemia Therapeutics Market: Competitive Structure
Table 7: Global: Acute Myeloid Leukemia Therapeutics Market: Key Players
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com